Tscan Therapeutics (TCRX) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.32
-0.3
-0.27
-0.25

Details

Expected EPS
-0.291667
Actual EPS
-0.26
Surprise EPS
0.03
Surprise Percent
+10.86%

Description

⁨Tscan Therapeutics⁩ (⁦TCRX⁩) has reported earnings of ⁦-0.26⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts